nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study
|
Soignet, Steven |
|
1997 |
40 |
1 |
p. S25-S29 |
artikel |
2 |
All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy
|
Asou, N. |
|
1997 |
40 |
1 |
p. S30-S35 |
artikel |
3 |
An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel
|
Zhang, Xichen |
|
1997 |
40 |
1 |
p. 81-86 |
artikel |
4 |
Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer
|
Mathews, John |
|
1997 |
40 |
1 |
p. 19-22 |
artikel |
5 |
Cellular uptake and antitumor activity of the new anthracycline analog DA-125 in human cancer cell lines
|
Lim, Kyoung-Hwa |
|
1997 |
40 |
1 |
p. 23-30 |
artikel |
6 |
Characterization of cellular accumulation and toxicity of illudin S in sensitive and nonsensitive tumor cells
|
Kelner, M. J. |
|
1997 |
40 |
1 |
p. 65-71 |
artikel |
7 |
Chemotherapy for small-cell lung cancer: more is not better
|
Saka, H. |
|
1997 |
40 |
1 |
p. S107-S109 |
artikel |
8 |
Chemotherapy: the more, the better in malignant lymphoma?
|
Tobinai, K. |
|
1997 |
40 |
1 |
p. S110-S114 |
artikel |
9 |
Chemotherapy: the more the better? Overview
|
Saijo, N. |
|
1997 |
40 |
1 |
p. S100-S106 |
artikel |
10 |
Combination chemotherapy involving orally administered etoposide and JM-216 in murine tumor models
|
Rose, William C. |
|
1997 |
40 |
1 |
p. 51-56 |
artikel |
11 |
Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin’s lymphoma
|
Fisher, R. I. |
|
1997 |
40 |
1 |
p. S42-S46 |
artikel |
12 |
Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity
|
An, Won G. |
|
1997 |
40 |
1 |
p. 60-64 |
artikel |
13 |
Design and analysis of trials of salvage therapy in acute myelogenous leukemia
|
Estey, Elihu |
|
1997 |
40 |
1 |
p. S9-S12 |
artikel |
14 |
Dose-intensive chemotherapy in extensive-stage small-cell lung cancer
|
Negoro, S. |
|
1997 |
40 |
1 |
p. S70-S73 |
artikel |
15 |
Dose-intensive therapy in lung cancer
|
Elias, Anthony |
|
1997 |
40 |
1 |
p. S64-S69 |
artikel |
16 |
Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line
|
Pendyala, L. |
|
1997 |
40 |
1 |
p. 38-44 |
artikel |
17 |
Establishment of a cisplatin-resistant gastric carcinoma cell line OCUM-2M/DDP
|
Nitta, Atsunori |
|
1997 |
40 |
1 |
p. 94-97 |
artikel |
18 |
Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines
|
Newkirk, Kenneth |
|
1997 |
40 |
1 |
p. 75-80 |
artikel |
19 |
High-dose carboplatin plus paclitaxel with granulocyte colony-stimulating factor and peripheral blood stem-cell support in non-small-cell lung cancer
|
Shea, T. C. |
|
1997 |
40 |
1 |
p. S74-S78 |
artikel |
20 |
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer
|
Tokuda, Y. |
|
1997 |
40 |
1 |
p. S94-S99 |
artikel |
21 |
High-dose chemotherapy with hematopoietic rescue in breast cancer: from theory to practice
|
Bezwoda, W. R. |
|
1997 |
40 |
1 |
p. S79-S87 |
artikel |
22 |
Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants
|
Holden, Sylvia A. |
|
1997 |
40 |
1 |
p. 87-93 |
artikel |
23 |
Importance of dose and dose intensity in the treatment of small-cell lung cancer
|
Murray, Nevin |
|
1997 |
40 |
1 |
p. S58-S63 |
artikel |
24 |
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
|
Sikic, B. I. |
|
1997 |
40 |
1 |
p. S13-S19 |
artikel |
25 |
Multidrug resistance: molecular mechanisms and clinical relevance
|
Ling, Victor |
|
1997 |
40 |
1 |
p. S3-S8 |
artikel |
26 |
New concepts in the treatment of breast cancer using high-dose chemotherapy
|
Peters, William P. |
|
1997 |
40 |
1 |
p. S88-S93 |
artikel |
27 |
New multidrug-resistance-reversing drugs, MS-209 and SDZ PSC 833
|
Naito, M. |
|
1997 |
40 |
1 |
p. S20-S24 |
artikel |
28 |
New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation
|
Kitamura, Kunio |
|
1997 |
40 |
1 |
p. S36-S41 |
artikel |
29 |
Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines
|
Yamada, Manabu |
|
1997 |
40 |
1 |
p. 31-37 |
artikel |
30 |
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial
|
Graham, Martin A. |
|
1997 |
40 |
1 |
p. 1-10 |
artikel |
31 |
Pharmacokinetics of trofosfamide and its dechloroethylated metabolites
|
Hempel, G. |
|
1997 |
40 |
1 |
p. 45-50 |
artikel |
32 |
Pharmacological considerations in high-dose chemotherapy
|
Sasaki, Yasutsuna |
|
1997 |
40 |
1 |
p. S115-S118 |
artikel |
33 |
Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies
|
Ogura, Michinori |
|
1997 |
40 |
1 |
p. S51-S57 |
artikel |
34 |
Preface
|
Saito, H. |
|
1997 |
40 |
1 |
p. S1-S2 |
artikel |
35 |
Quantification of 4-hydroxyifosfamide in plasma of ifosfamide-treated mice
|
Struck, R. F. |
|
1997 |
40 |
1 |
p. 57-59 |
artikel |
36 |
Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo
|
Nagai, Naomi |
|
1997 |
40 |
1 |
p. 11-18 |
artikel |
37 |
Thiotepa and etoposide treatment of recurrent malignant gliomas: phase I study
|
Balmaceda, Casilda |
|
1997 |
40 |
1 |
p. 72-74 |
artikel |
38 |
Treatment for adult T-cell leukemia
|
Hanada, S. |
|
1997 |
40 |
1 |
p. S47-S50 |
artikel |